Vascular endothelial growth factor as a target for antiangiogenic therapy.
Gordon
M S
MS
University of Arizona College of Medicine, Phoenix, AZ, USA. msgordon@u.arizona.edu
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D016228:Endothelial Growth Factors / Q000096:biosynthesis / Q000502:physiology*; D006801:Humans; D008222:Lymphokines / Q000096:biosynthesis / Q000502:physiology*; D009369:Neoplasms / Q000098:blood supply*; D009389:Neovascularization, Pathologic / Q000188:drug therapy* / Q000378:metabolism; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D020533:Angiogenesis Inhibitors; D016228:Endothelial Growth Factors; D008222:Lymphokines; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors